Financhill
Back

Rocket Pharmaceuticals Quote, Financials, Valuation and Earnings

Rocket Pharmaceuticals Price Quote

$15.68
-0.35 (-2.18%)
(Updated: November 13, 2024 at 5:55 PM ET)

Rocket Pharmaceuticals Key Stats

Sell
33
Rocket Pharmaceuticals (RCKT) is a Sell

Day range:
$15.92 - $17.20
52-week range:
$15.92 - $32.53
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
0.00
P/B ratio:
4.43%

Volume:
965.1K
Avg. volume:
754.5K
1-year change:
-13.58%
Market cap:
$1.5B
Revenue:
$0
EPS:
$-2.75

How Much Does Rocket Pharmaceuticals Make?

Data Unavailable

Is Rocket Pharmaceuticals Growing As A Company?

Data Unavailable

Rocket Pharmaceuticals Stock Price Performance

What Is Rocket Pharmaceuticals 52-Week High & Low?

Rocket Pharmaceuticals Price To Free Cash Flow

Data Unavailable

Is It Risky To Buy Rocket Pharmaceuticals?

Is Rocket Pharmaceuticals Cash Flow Positive?

  • What Is RCKT Cash Flow From Operations?
    Cash flow from operations (TTM) is -$192.1M
  • What Is Rocket Pharmaceuticals’s Cash Flow From Financing?
    Cash flow from financing (TTM) is $3.3M
  • What Is Rocket Pharmaceuticals’s Cash Flow From Investing?
    Cash flow from investing (TTM) is $28.8M

Rocket Pharmaceuticals Return On Invested Capital

Data Unavailable

Rocket Pharmaceuticals Earnings Date & Stock Price

Rocket Pharmaceuticals Competitors

Rocket Pharmaceuticals Dividend Yield

Rocket Pharmaceuticals Analyst Estimates

YoY Growth Past Surprise
EPS: 0% 5.34%
Revenue: 0% 0%

Analyst Recommendations

Buy Recommendations: 11
Hold Recommendations: 1
Sell Recommendations: 0
Price Target: 46.86
Upside from Last Price: 192.31%

Major Shareholders

  • How many RCKT shares are owned by institutional investors?
    127.4M RCKT shares are owned by institutional investors
  • How many RCKT shares are owned by insiders?
    1.6M RCKT shares are owned by insiders